Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Healthpeak Properties (DOC)

Healthpeak raises 2024 EPS guidance to $0.27 to $0.31 as Q2 net income rises

Positive Impact 4 of 5 guidance Written later

Healthpeak Properties reported second-quarter 2024 results on July 25, 2024, with diluted net income of $0.21 per share, up from $0.09 a year earlier, while Nareit FFO was $0.44 per share, down from $0.45. The company raised its full-year 2024 diluted earnings per share guidance to $0.27 to $0.31 from $0.16 to $0.20. For shareholders, higher earnings guidance is offset in part by a slight decline in FFO per share, a key REIT measure.

Key points

  • Q2 2024 diluted net income of $0.21 per share vs. $0.09 in Q2 2023; Nareit FFO $0.44 vs. $0.45; AFFO $0.39 vs. $0.40
  • Full-year 2024 diluted EPS guidance raised to $0.27 to $0.31 from $0.16 to $0.20; diluted Nareit FFO guidance raised to $1.59 to $1.63 from $1.56 to $1.60
  • Quarterly common dividend of $0.30 per share declared July 24, 2024, payable August 16, 2024, to holders of record on August 5, 2024
  • New $500 million share repurchase authorization effective through July 2026, replacing the existing authorization

The filing

CompanyHealthpeak Properties (DOC)
Form8-K, current report
Filed with the SECJul 25, 2024, 4:17 PM ET
Accession number0001628280-24-032991

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 25, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.